Member Info for stan1234

I want more

Called x

But nah

Amount to revenue to Fusion of approximately £200,000, all of which is expected to be recognised in the current financial year. Additionally, royalties will also be due on commercial sales of the final product once successfully approved.

This Contract is separate and in addition to the $650,000 follow-on project currently being undertaken for the Client, details of which were announced on 6 February 2024.

Adding more

This was double figures not so long ago

Recorded as well

5-6p soon

Bulls moving it up.

Yh

5-6p

Any more clues?

Volume

Maybe misunderstood

Rumours might discourage people.

Depressing to watch the comments

Putting traders off

Taken from last broker note, this month,

“Potential collaboration to validate OptiMAL: Fusion disclosed that it is in advanced discussions with a top-tier firm to collaborate in a project that could validate OptiMAL.“

Fusion advised discussions regarding a collaboration to validate OptiMA with a top-tier firm

Https://www.linkedin.com/posts/fusion-antibodies-plc_pegseurope-antibodydiscovery-antibodyengineering-activity-7130478774076235776-9U1p?utm_source=share&utm_medium=member_ios